Condition: Type 2 Diabetes Mellitus · Type2diabetes · Diabetes Mellitus, Type 2 · Sponsor: Endogenex, Inc.
This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes (T2D) inadequately controlled on non-insulin glucose-lowering medications.
This description comes directly from the study's public registry record.
Marie Steinbrink, MS · (763) 251-6827 · recetstudy@endogenex.com
Always discuss trial participation with your own doctor first.
| University of Alabama | Birmingham, Alabama, United States | Recruiting |
| Central Alabama Research | Birmingham, Alabama, United States | Recruiting |
| Velocity Clinical Research, Gardena | Gardena, California, United States | Recruiting |
| Cedars-Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| UCLA | Los Angeles, California, United States | Recruiting |
| Hoag Memorial Hospital Presbyterian - Digestive Health Institute | Newport Beach, California, United States | Recruiting |
| Velocity Clinical Research, Panorama City | Panorama City, California, United States | Withdrawn |
| Velocity Clinical Research, Hallandale Beach | Hallandale, Florida, United States | Recruiting |
| Mayo Clinic | Jacksonville, Florida, United States | Recruiting |
| Universal Axon Clinical Research LLC | Miami, Florida, United States | Recruiting |
| University of Miami | Miami, Florida, United States | Recruiting |
| Quantum Clinical Research | Miami Beach, Florida, United States | Recruiting |
+ 33 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06267391